SCHEMBL4038698

SCHEMBL4038698

Cc1cccc(Cl)c1Nc1nc2cnc(N3CC(C)NC(C)C3)cc2n2cncc12

nearest known ligand 0.77

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.77
SRC P12931 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4038704 1.00 LCK (0.77) LCKSRC
SCHEMBL4038002 0.91 LCK (0.75) LCKSRC
SCHEMBL7987217 0.87 LCK (1.00) LCKSRC
SCHEMBL7980086 0.86 LCK (1.00) LCKSRC
SCHEMBL4040593 0.85 LCK (0.83) LCKSRC
SCHEMBL7983578 0.84 LCK (1.00) LCKSRC
SCHEMBL7983576 0.84 LCK (1.00) LCKSRC
SCHEMBL7981233 0.83 LCK (0.95) LCKSRC
SCHEMBL7981234 0.83 LCK (0.95) LCKSRC
SCHEMBL4042900 0.81 LCK (0.74) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1066286-B1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2009-04-29 EP claimed
EP-1066286-B1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2009-04-29 EP disclosed
US-5990109-A NOVEL COMPOUNDS, METHODS OF THEIR SYNTHESIS, AND THEIR USE IN TREATING VARIOUS TYROSINE KINASE-ASSOCIATED IMMUNOLOGICAL DISORDERS, SUCH AS RHEUMATOID ARTHRITIS, MULTIPLE SCLEROSIS, GRAFT VS. HOST DISEASE, LUPUS, PSORIASIS AND ASTHMA BRISTOL-MYERS SQUIBB CO. (US) 1999-11-23 US disclosed